메뉴 건너뛰기




Volumn 91, Issue 5, 2007, Pages 566-567

Topical azithromycin: New evidence?

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; TETRACYCLINE;

EID: 34248142836     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.107102     Document Type: Editorial
Times cited : (6)

References (10)
  • 1
    • 34248215088 scopus 로고    scopus 로고
    • Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children - a randomised, controlled, double-masked clinical trial
    • Cochereau I, Goldschmidt P, Goepogui A, et al. Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children - a randomised, controlled, double-masked clinical trial. Br J Ophthalmol 2006;91:667-72.
    • (2006) Br J Ophthalmol , vol.91 , pp. 667-672
    • Cochereau, I.1    Goldschmidt, P.2    Goepogui, A.3
  • 3
    • 7444228636 scopus 로고    scopus 로고
    • High coverage mass treatment with single-dose azithromycin interrupts transmission of trachoma
    • Solomon AW, Holland MJ, Alexander ND, et al. High coverage mass treatment with single-dose azithromycin interrupts transmission of trachoma. N Engl J Med 2004;351:1962-71.
    • (2004) N Engl J Med , vol.351 , pp. 1962-1971
    • Solomon, A.W.1    Holland, M.J.2    Alexander, N.D.3
  • 4
    • 0033592130 scopus 로고    scopus 로고
    • Azithromycin in control of trachoma
    • Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet 1999;354:630-5.
    • (1999) Lancet , vol.354 , pp. 630-635
    • Schachter, J.1    West, S.K.2    Mabey, D.3
  • 5
    • 3843120993 scopus 로고    scopus 로고
    • Feasibility of eliminating ocular chlamydia trachomatis with repeat mass antibiotic treatments
    • Melese M, Chidambaram JD, Alemayehu W, et al. Feasibility of eliminating ocular chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 2004;292:721-5.
    • (2004) JAMA , vol.292 , pp. 721-725
    • Melese, M.1    Chidambaram, J.D.2    Alemayehu, W.3
  • 6
    • 26244436818 scopus 로고    scopus 로고
    • Infection with chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: A longitudinal study
    • West SK, Munoz B, Mkocha H, et al. Infection with chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005;366:1296-300.
    • (2005) Lancet , vol.366 , pp. 1296-1300
    • West, S.K.1    Munoz, B.2    Mkocha, H.3
  • 7
    • 79953282726 scopus 로고    scopus 로고
    • Mabey D, Fraser-Hurt N, Powell C. Antibiotics for trachoma. Cochrane Database of Systematic Reviews 2005, Issue 2. Art.No.:CD001860.pub2.
    • Mabey D, Fraser-Hurt N, Powell C. Antibiotics for trachoma. Cochrane Database of Systematic Reviews 2005, Issue 2. Art.No.:CD001860.pub2.
  • 9
    • 33750744086 scopus 로고    scopus 로고
    • Elimination of trachoma: Are we in danger of being blinded by the randomised controlled trial?
    • Wright HR, Keeffe JE, Taylor HR. Elimination of trachoma: are we in danger of being blinded by the randomised controlled trial? Br J Ophthalmol 2006;90:1339-42.
    • (2006) Br J Ophthalmol , vol.90 , pp. 1339-1342
    • Wright, H.R.1    Keeffe, J.E.2    Taylor, H.R.3
  • 10
    • 0030914877 scopus 로고    scopus 로고
    • Reduction of trachoma in a sub-Saharan village in absence of a disease control programme
    • Dolin PJ, Faal H, Johnson GJ, et al. Reduction of trachoma in a sub-Saharan village in absence of a disease control programme. Lancet 1997;349:1511-12.
    • (1997) Lancet , vol.349 , pp. 1511-1512
    • Dolin, P.J.1    Faal, H.2    Johnson, G.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.